United States: Questions Remain For The EHR Industry As A Second EHR Vendor, Greenway Health, Settles False Claims Act Allegations

On February 6, 2019, the DOJ announced a settlement agreement with Greenway Health, a vendor of EHR software, under which Greenway agreed to pay approximately $57 million to resolve allegations that it caused its health care provider customers to submit false claims for payments under the Medicare and Medicaid EHR incentive programs in violation of the False Claims Act.

Many of the allegations against Greenway are very similar to the allegations that eClinicalWorks (eCW) settled with DOJ in 2017. For more information about the eCW settlement and CIA, see our On the Subject.

DOJ announced on February 6, 2019, the Settlement Agreement resolving allegations in DOJ's Complaint that Greenway caused its customers to submit false Medicare and Medicaid claims for payments under the EHR Incentive Programs in violation of the FCA and that it paid illegal kickbacks to current customers to recommend Greenway products (that are used to generate incentive payments or avoid penalties under the EHR Incentive Programs) to new customers. Under the Settlement Agreement, Greenway agreed to pay approximately $57 million to resolve the allegations without admitting liability. Greenway also entered into a five-year CIA with strict compliance oversight, reporting obligations and costly obligations to provide the latest version of Greenway's EHR software to each of Greenway's current customers at no additional charge.

This settlement comes nearly two years after eCW entered into a groundbreaking settlement with DOJ. At that time, we wondered whether it may be a sign of increasing FCA actions against vendors of EHR technology (CEHRT) certified through the health information technology (HIT) certification program of the Office of the National Coordinator of HIT (ONC). Statements by the United States Attorney for the District of Vermont, Christina E. Nolan, in the DOJ press release discussing the Greenway settlement seem to answer that question very directly in the affirmative. She says that "EHR companies should consider themselves on notice." It is notable that, unlike the eCW case, the Greenway case was not initiated by a relator, but pursued by DOJ directly. In light of the government's continued focus on vendors of EHR technology used to earn payments or avoid penalties for failing to succeed under the EHR Incentive Programs (or their successor value-based payment programs), HIT vendors should:

  • Take care to accurately and transparently demonstrate their software during HIT certification program testing
  • Review, and consider improvements to, their systems and other procedures for identifying, responding to and correcting software design and quality issues that call into question EHR software's conformity to applicable EHR certification criteria or present patient safety or clinician usability risks; and
  • Review existing customer reference, referral and marketing arrangements for compliance with the Anti-Kickback Statute.

The following sections of this On the Subject discuss the key elements and implications of the Complaint and CIA.

Allegations

Just like in the eCW case, DOJ's Complaint alleged that Greenway made false statements about Greenway's EHR software and made improper payments (i.e., kickbacks) to referral sources in violation of the Anti-Kickback Statute. In addition, the Greenway case also involved allegations related to improper calculation of certain EHR incentive program measures.

False Statements

First, DOJ alleged that, in an effort to be one of the first companies with its product certified to the 2014 Edition of ONC's EHR certification criteria, Greenway attempted to "shortcut" certain functionality, allowing its software to pass certification testing, without actually having all of the functionality required under the certification program regulations. According to DOJ, Greenway hard coded its software to pass publicly available test scripts relating to the use of RxNorm and SNOMED CT standards, even though at the time of testing and certification, as well as later when deployed "in the field," Greenway's software did not fully utilize those standards as required. DOJ asserted that, notwithstanding this, Greenway falsely represented to the entity performing the testing and certification that Greenway's software met the required certification criteria and could do so when deployed in production (i.e., outside of the testing environment during live use with patients) in order to obtain certification. Because of this alleged false representation, DOJ asserts, Greenway's software did not qualify as CEHRT. However, in order to be eligible for incentive payments under the EHR incentive program (or, more recently, avoid downward adjustments in Medicare reimbursement under the Medicare Physician Fee Schedule or Medicare Inpatient Prospective Payment System), health care providers are required to use CEHRT in accordance with "meaningful use" objectives and measures under the Incentive Programs.

As a result, DOJ alleged that Greenway caused its customers to receive unearned EHR incentive payments by submitting false attestations of meaningful use of CEHRT. Based on the Complaint, and just like in the eCW case, it appears that DOJ did not pursue Greenway's customers for the unearned incentive payments, in part, because Greenway's customers "unknowingly" submitted false attestations (reasonably believing that the Greenway EHR software was properly certified as reported on the ONC's website) and the FCA requires the government to establish that false claims were submitted knowingly. CMS issued a statement that it would not view any meaningful use payment to eCW users as overpayments where those providers relied in good faith on eCW's representation that its product qualified as CEHRT. Presumably, CMS would take the same position for Greenway customers.

Inflated Incentive Program Measures

In addition to using CEHRT, health care providers were required achieve certain meaningful use measures to be eligible for incentive payments under the EHR Incentive Programs. DOJ alleged that an earlier version of Greenway's EHR software miscalculated a particular measure related to clinical care summaries, that Greenway became aware of the issue in the middle of a performance year and that Greenway chose not to correct it to avoid having customers that previously thought they were on target to receive incentive payments (based on the miscalculation) actually fail to meet the measure and miss out on incentive payments. Additionally, even after Greenway rolled out a patch to fix the problem for the subsequent Incentive Program year, DOJ asserted that some customers did not receive the patch until later in that year and found themselves in the same position as before—they appeared to be on target to meet the measure when they were, in fact, not. So Greenway, DOJ alleges, provided the affected customers with incorrect calculations in order to receive incentive payments.

Kickbacks

Like in the eCW case, DOJ alleged that certain payments from Greenway to its customers pursuant to certain reference and referral programs violated the Anti-Kickback Statute. Despite nearly tripling the number of pages dedicated to the kickback discussion in the Greenway complaint (from one page in the eCW complaint-in-intervention to nearly three in the Greenway case), the details about DOJ's objections to site visit and reference programs—which could be viewed as typical and commercially reasonable marketing arrangements for information technology that involve customers providing actual marketing services in exchange for the payment—remain scant. Further, federal courts may interpret the Anti-Kickback Statute differently than DOJ and conclude, contrary to the DOJ's assertions in the Complaint, that commercially reasonable marketing arrangements are not kickbacks.

For example, it is a common commercial practice to select references who will be complimentary of the organization or product that is the subject of the reference rather than selecting references who will be unenthusiastic, neutral or negative. Yet, DOJ seems to view this practice as suspect. We note that it does not appear DOJ has pursued these types of marketing arrangements absent an allegation of misrepresentations about the software's certification. In other words, that DOJ may view engaging customers (to whom DOJ believes the company made misrepresentations) to market that product to others as a problematic activity undertaken to further promote the misrepresented product.

The OIG has for years consistently stated that marketing payments technically implicate the Anti-Kickback Statute, but it has also recognized that payment for marketing services are commonplace, and in fact, unavoidable without banning marketing activities entirely. Various advisory opinions and other guidance set forth a multi-factored facts-and-circumstances analysis for distinguishing between proper and improper marketing activities outside the Anti-Kickback Statute safe harbors. The analysis examines the nature of the payment, the type of marketing activity (i.e., active or passive), the type of item or service marketed, the intended audience, and the identity of the marketer and his or her relationship with the intended audience. However, the presence or absence of any of these factors does not necessarily mean that an arrangement violates the Anti-Kickback Statute. Yet DOJ's discussion of the kickback allegations in the Greenway Complaint, as in the eCW complaint-in-intervention, does not seem to apply this long-standing analytical framework for marketing arrangements.

Ongoing CIA Requirements

In addition to the large monetary settlement payment, Greenway agreed to comply with requirements in a CIA that were similar to those imposed on eCW. What were novel requirements in 2017 appear to have become the standard when OIG imposes CIA obligations on EHR vendors in connection with these types of cases. For example, the CIA requires Greenway to retain an independent review organization or organizations to assess its software quality controls and compliance systems and to review arrangements for compliance with the Anti-Kickback Statute. Further, Greenway is required to offer its customers the option of receiving a free upgrade or transfer to alternative Greenway product or to transfer data to another vendor's EHR product without cost.

Implications for HIT Vendors

The Greenway settlement demonstrates continued scrutiny of EHR vendors by the government for compliance with the EHR certification criteria because CEHRT may enable health care providers to earn incentive payments or other enhanced reimbursement or avoid decreased reimbursement under more recent federal health care program rules. The CIA makes clear that the government is not only concerned about improper reimbursement to health care providers, but also patient safety issues caused by defective software and poor usability as well as kickbacks to referral sources. Consequently, EHR and other HIT vendors should consider the following steps:

  • Develop and implement a compliance program that reflects the elements of an effective corporate compliance program set forth in DOJ and OIG compliance program guidance for the health care industry;
  • Develop and implement policies, procedures and practices for addressing EHR certification criteria, patient safety and EHR usability considerations into the ongoing software development and design process;
  • Develop and implement procedures for employees, customers and other persons to report patient safety, usability and compliance issues to vendor management and procedures for promptly tracking, monitoring and resolving the issues;
  • Identify, review and resolve any currently known or suspected EHR certification criteria compliance issues and patient safety issues;
  • Evaluate current showcase or reference site arrangements, referral arrangements and other marketing arrangements outside the Anti-Kickback Statute safe harbors with persons in a position to generate new customers and new business to determine whether they reasonably comply with OIG guidance regarding marketing;
  • Develop and implement policies, procedures and practices for complying with the Anti-Kickback Statute, including policies for evaluating whether marketing arrangements with referral sources comply with the Anti-Kickback Statute; and
  • Implement a comprehensive training program to address the range of health care regulatory compliance matters addressed by the CIA and foster a culture of health care regulatory compliance.

Questions Remain For The EHR Industry As A Second EHR Vendor, Greenway Health, Settles False Claims Act Allegations

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Mondaq Sign Up
Gain free access to lawyers expertise from more than 250 countries.
 
Email Address
Company Name
Password
Confirm Password
Country
Position
Industry
Mondaq Newsalert
Select Topics
Select Regions
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions